N = 53 | |
---|---|
Age, years | 63.0 ± 9.3 |
Female gender, female (%) | 17 (32.1) |
Body mass index, kg/m2 | 27.4 ± 3.5 |
Cardiovascular risk factors | |
Hypertension, N (%) | 42 (79.2) |
Hypercholesterolemia, N (%) | 36 (67.9) |
Diabetes, N (%) | 11 (20.8) |
Smoking, N (%) | 8 (15.1) |
Framingham 10 years risk,% | 13 ± 7 |
History of coronary artery disease | |
Known coronary artery disease, N (%) | 34 (64.2) |
Known myocardial infarction, N (%) | 18 (34.0) |
Medication | |
β- Blocker, N (%) | 34 (64.2) |
AT1-Inhibitor/ACE-Inhibitor, N (%) | 39 (73.6) |
Statin, N (%) | 40 (75.5) |
Platelet aggregation inhibitor, N (%) | 46 (86.8) |
Ventricular volumes and function | |
Left ventricular ejection fraction,% | 61 ± 9 |
Left ventricular end-diastolic volume index, ml/m2 | 81 ± 15 |
Left ventricular mass index, g/m2 | 54 ± 10 |
Right ventricular ejection fraction,% | 63 ± 6 |
Right ventricular end-diastolic volume index, ml/m2 | 72 ± 14 |
Quantitative coronary angiography | |
Patients with stenosis ≥ 70%, N (%) | 25 (47.2) |
1-vessel disease | 15 (28.3) |
Multi-vessel disease | 10 (18.9) |